{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:159269",
      "entity_text" : "telbivudine",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pfam:PF03059",
      "entity_text" : "NAs",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Mallet et al. reported that patients who were born in HBV endemic areas with initial high HBV DNA levels (more than 5 log IU/mL) were more likely to have increased eGFR with treatment by NAs other than telbivudine [XREF_BIBR].",
  "reading_complete" : "2020-08-08T12:24:20Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T12:20:49Z",
  "trigger" : "increased",
  "evidence" : [ "increased eGFR with treatment by NAs other than telbivudine" ],
  "pmc_id" : "5516758",
  "score" : 0
}